Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling
- 12 August 2010
- journal article
- Published by American Society of Hematology in Blood
- Vol. 116 (6), 953-961
- https://doi.org/10.1182/blood-2010-01-263806
Abstract
The genome of mantle cell lymphoma (MCL) is, in addition to the translocation t(11;14), characterized by a high number of secondary chromosomal gains and losses that probably account for the various survival times of MCL patients. We investigated 77 primary MCL tumors with available clinical information using high-resolution RNA expression and genomic profiling and applied our recently developed gene expression and dosage integrator algorithm to identify novel genes and pathways that may be of relevance for the pathobiology of MCL. We show that copy number neutral loss of heterozygosity is common in MCL and targets regions that are frequently affected by deletions. The molecular consequences of genomic copy number changes appear complex, even in genomic loci with identified tumor suppressors, such as the region 9p21 containing the CDKN2A locus. Moreover, the deregulation of novel genes, such as CUL4A, ING1, and MCPH1, may affect the 2 crucial pathogenetic mechanisms in MCL, the disturbance of the proliferation, and DNA damage response pathways. Deregulation of the Hippo pathway may have a pathogenetic role in MCL because decreased expression of its members MOBKL2A, MOBKL2B, and LATS2 was associated with inferior outcome, including an independent validation series of 32 MCLs.This publication has 45 references indexed in Scilit:
- Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profilingBlood, 2009
- DDB1-CUL4 and MLL1 Mediate Oncogene-Induced p16INK4a ActivationCancer Research, 2009
- The Hippo–YAP pathway: new connections between regulation of organ size and cancerCurrent Opinion in Cell Biology, 2008
- Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene‐dosage regulated candidate genesBritish Journal of Haematology, 2008
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathwaysProceedings of the National Academy of Sciences of the United States of America, 2008
- MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosisEMBO Reports, 2008
- Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysisBMC Cancer, 2008
- External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinomaCancer, 2008
- Specific Secondary Genetic Alterations in Mantle Cell Lymphoma Provide Prognostic Information Independent of the Gene Expression–Based Proliferation SignatureJournal of Clinical Oncology, 2007
- BRIT1 regulates early DNA damage response, chromosomal integrity, and cancerCancer Cell, 2006